Teladoc Health (NYSE: TDOC) is somewhat of a hybrid company, caught between technology and healthcare. The company is considered a software company, but it provides on-demand healthcare services—an interesting mix of attributes. Regardless of what the company does, the stock has been in a downward trend for the last seven months.
The decline started last October and it saw the stock drop from over $85 a share to $42.50 in December. The stock rallied back in January and February, but then turned lower again in March. If we connect the high closing prices from September and February we get a downward sloped trend line and the stock has rallied up to that line in recent weeks.
In addition to the trend line, we see that the stock is struggling to move back above its 50-day moving average. It moved above it on May 1, but it couldn’t maintain the momentum in to the close. We also see that the daily stochastic readings are in overbought territory and made a bearish crossover on May 1.
Teladoc’s fundamentals are below average, at least in terms of its earnings growth and management efficiency measurements. The company saw earnings decline by 10% in its fourth quarter report and earnings have been flat over the last three years. The company is set to report again on May 6.
Because the company has been losing money, the return on equity is currently -12.35% and the profit margin is -23.2%.
The Tickeron AI Prediction tool generated a bearish signal on Teladoc on April 30 and that signal calls for a decline of at least 4% over the next month. The signal showed a confidence level of 66% while previous predictions for the stock have been successful 64% of the time.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
TDOC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TDOC as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
TDOC moved below its 50-day moving average on July 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TDOC crossed bearishly below the 50-day moving average on August 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TDOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TDOC's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TDOC advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .
TDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 170 cases where TDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.886) is normal, around the industry mean (7.638). TDOC has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.808). TDOC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.726). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.459) is also within normal values, averaging (6.460).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TDOC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TDOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a telephone and online video consultation service
Industry ServicestotheHealthIndustry